Aktualności

BEIJING, AUGUST 24, 2021 - Lepu Medical Technology (Beijing) Co., Ltd. (“Lepu Medical”), a leading global company specialized in developing, manufacturing and marketing high-tech medical devices and equipment, today announced that its Sterylna strzykawka do linii jednorazowego użytku Uzyskał aprobatę CE Mark do ogólnego użytku, w tym do dostarczania różnych szczepionek COVID-19.

Znak CE wskazuje, że sterylna strzykawka Lepu Medical do jednorazowego użytku spełnia normy kategorii Unii Europejskiej (UE) dotyczące bezpieczeństwa i skuteczności stosowania przez pracowników służby zdrowia do ogólnego przeznaczenia płynów i wstrzyknięć, co sprawia, że są one dostępne do profesjonalnego zakupu w całej UE i innych kraje, które uznają znak CE.

Lepu Medical’s Sterylna strzykawka do linii jednorazowego użytku has received CE Mark approval at a time of high-demand for needles suitable to vaccinate populations against the COVID-19 pandemic.  Lepu Medical’s syringe series offers a variety of single-use needles for many applications, including various COVID-19 vaccines. The line includes both Luer Lock and Lock Slip syringes, a clear barrel, plunger, plunger stopper, needle, and cap. Lepu Medical’s syringe series offers a higher resistance to breakage in single-use, and latex-free pistons. The total graduated capacity of all models of syringes is 1mL, with a range of needle sizes to meet a variety of injection and COVID-19 vaccine needs, each distinguished by the color of the needle hub.

Designed to meet a variety of injection needs, Lepu Medical’s Sterile Syringe For Single-Use brings improved safety to patients and doctors with its clear barrel for convenient control of foreign substances. The Sterile Syringe For Single-Use is intended only for one-time use by  healthcare professionals who have received training on medical injection techniques. Injection and vaccine administrators can refer to the Lepu Medical professional manual before use for a full understanding of the device instructions, warnings and precautions.

Oprócz sterylnej strzykawki do jednorazowego użytku, Lepu Medical dostarczyło różne środki medyczne do zapobiegania i kontroli COVID-19, w tym SARS-CoV-2 zestaw do szybkiego testu antygenu do samodzielnego testowania oraz zestaw do SARS-CoV-2 testów przeciwciał do profesjonalnych testów medycznych. Lepu Medical oferuje również COVID-19 rozwiązania diagnostyczne, takie jak produkty kwasu nukleinowego i rozwiązania zapewniające standardowe testy do diagnozowania COVID-19 oraz produkty do testowania przeciwciał w celu monitorowania poziomu odporności COVID-19. Inne COVID-19 produkty i rozwiązania Lepu Medical obejmują zestawy do pobierania próbek, ręczne zestawy do ekstrakcji próbek, zautomatyzowane ekstraktory próbek i systemy PCR w czasie rzeczywistym do standardowej klinicznej diagnostyki kwasów nukleinowych.

As of August 2021, the number of global daily doses of COVID-19 vaccines continues to rise, driving demand for vaccines and vaccination supplies. According to published statistics, by the end of 2020, major governments had placed purchases for over nine billion vaccine units. With the onset of the Delta virus, vaccination rates are ramping up and the expected number of vaccine units is increasing. Government officials and medical professionals across the globe from Israel, France, Germany, the U.S, the United Arab Emirates, Bahrain, the United Kingdom, Switzerland, Cambodia and others are proposing and actively preparing for the third dose of the COVID-19 vaccination to strengthen pandemic prevention and control efforts. With the CE Mark approval for the Sterile Syringe For Single-Use, Lepu Medical will continue to proactively seek qualified partners to support the availability of reliable vaccine supplies across the globe, and assist with COVID-19 management and continuation of general medical practices.